This is an investigational study. Cyclophosphamide is FDA approved and commercially available for the treatment of several types of cancer such as leukemia, lymphoma, and breast cancer. Fludarabine is FDA approved and commercially available for the treatment of B-cell chronic lymphocytic leukemia. It is considered investigational to give cyclophosphamide and fludarabine to treat melanoma.